HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N- (1- (3,4- dihydroxyphenyl)propan- 2- yl)oleamide

a dual CB1 receptor antagonist/PPARalpha agonist

Also Known As:

OLHHA

Networked: 1 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Lipids: 114793
- Fatty Acids: 27405
  - Unsaturated Fatty Acids: 8236
    - Monounsaturated Fatty Acids: 676
      - Oleic Acids: 67
        N-(1-(3,4-dihydroxyphenyl)propan-2-yl)oleamide: 1

Experts

1.	Almeida, Bruno: 1 article (10/2015)
2.	Baixeras, Elena: 1 article (10/2015)
3.	Decara, Juan M: 1 article (10/2015)
4.	Gavito, Ana L: 1 article (10/2015)
5.	Joglar, Jesús: 1 article (10/2015)
6.	Pavón, Francisco Javier: 1 article (10/2015)
7.	Rivera, Patricia: 1 article (10/2015)
8.	Rodríguez de Fonseca, Fernando: 1 article (10/2015)
9.	Romero-Cuevas, Miguel: 1 article (10/2015)
10.	Serrano, Antonia: 1 article (10/2015)

Related Diseases

1.	Obesity 10/01/2015 - "The present results demonstrate that OLHHA is a potential anti-steatotic drug that ameliorates the obesity-associated fatty liver and suggest the potential use of this new drug for the treatment of non-alcoholic fatty liver disease." 10/01/2015 - "In this study, we have characterized the in vivo effects of a novel conjugation of oleic acid with an amphetamine derivative (OLHHA) in an animal model of genetic obesity. "
2.	Non-alcoholic Fatty Liver Disease 10/01/2015 - "The present results demonstrate that OLHHA is a potential anti-steatotic drug that ameliorates the obesity-associated fatty liver and suggest the potential use of this new drug for the treatment of non-alcoholic fatty liver disease."
3.	Fatty Liver 10/01/2015 - "The present results demonstrate that OLHHA is a potential anti-steatotic drug that ameliorates the obesity-associated fatty liver and suggest the potential use of this new drug for the treatment of non-alcoholic fatty liver disease."
4.	Drug-Related Side Effects and Adverse Reactions 10/01/2015 - "The potential of OLHHA to produce adverse drug reactions or toxicity was also evaluated through the monitoring of interactions with hERG channel and liver cytochrome. "

Related Drugs and Biologics

1.	Oleic Acid (Oleate)
2.	Amphetamine (Amfetamine)
3.	Cytochromes